STAT

STAT+: Health care leaders plot how to expand diversity in clinical trials

Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
Silas Buchanan, CEO of OurHealthyCommunity, speaks on a panel about democratizing clinical trials at the Milken Institute 2024 Global Conference on May 8, 2024 as Michelle McMurry-Heath, CEO of Biotechquity Clinical looks on.

Even with the that clinical trials often lack the diversity that would make them representative, women and people of color remain underrepresented in

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Opinion: STAT+: Eli Lilly Chief Scientist Daniel M. Skovronsky: Beware Elected Leaders Who Would Weaken Patents
“Unfortunately, many of our elected leaders today undervalue the role of patents to progress the science of drug discovery and look for policies to weaken them,” writes Eli Lilly’s Daniel…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Doctors Powering Telehealth GLP-1 Scripts, An FDA Hold On A Novavax Shot, And More
A handful of clinician networks write prescriptions for dozens of websites offering the GLP-1 weight loss drugs
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, What Drugmakers Didn’t Tell Alzheimer’s Trial Patients And More
Plus: Ozempic linked to a lower risk of Alzheimer’s diagnosis among people with type 2 diabetes

Related Books & Audiobooks